Inviting patients with inflammatory bowel disease to active involvement in their own care: A randomized controlled trial

Inflammatory Bowel Diseases

Volumn 20, Issue 6, 2014, Pages 1057-1069

  Hueppe, Angelika ^a   Langbrandtner, Jana ^a   Raspe, Heiner ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Inflammatory bowel disease; Patient activation; Randomized controlled trial; Self management

Indexed keywords

ADULT; ARTICLE; CONSULTATION; CONTROLLED STUDY; CROHN DISEASE; DISABILITY; DISEASE ACTIVITY; FEMALE; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HEALTH EDUCATION; HUMAN; INFLAMMATORY BOWEL DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; OUTPATIENT CARE; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESPONSIBILITY; SELF CARE; SELF EVALUATION; SOCIAL PARTICIPATION; ULCERATIVE COLITIS; VISUAL ANALOG SCALE; CLINICAL PATHWAY; COLITIS, ULCERATIVE; DOCTOR PATIENT RELATION; FOLLOW UP; HEALTH SERVICE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT PARTICIPATION; PATIENT SATISFACTION; PROCEDURES; PSYCHOLOGY; TREATMENT OUTCOME; UTILIZATION;

ADULT; COLITIS, ULCERATIVE; CRITICAL PATHWAYS; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HEALTH SERVICES; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT PARTICIPATION; PATIENT SATISFACTION; PHYSICIAN-PATIENT RELATIONS; QUALITY OF LIFE; SELF CARE; TREATMENT OUTCOME;

EID: 84902124915     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000044     Document Type: Article

References (74)

1. Burisch J, Jess T, Martinato M., et al The burden of inflammatory bowel disease in Europe. J Crohns Colitis. 2013; 7: 322-337.
2. Kemp K, Griffiths J, Lovell K. Understanding the health and social care needs of people living with IBD: a meta-synthesis of the evidence. World J Gastroenterol. 2012; 18: 6240-6249.
3. Hueppe A, Langbrandtner J, Raspe H. Assessing complex health problems of patients with IBD-first step to patient activation. Z Gastroenterol. 2013; 51: 257-270.
4. Hardt J, Muche-Borowski C, Conrad S., et al Inflammatory bowel diseases as multi-focal disorders: results from a multi-regional survey on bodily and psychosocial problems in IBD patients. Z Gastroenterol 2010; 48: 381-391.
5. European Crohn's and Colitis Organisation. ECCO Consensus Guidelines for IBD. Ulcerative Colitis (UC) Guidelines. Vienna, Austria: ECCO; 2008.
6. European Crohn's and Colitis Organisation. ECCO Consensus Guidelines for IBD. Crohn's Disease (CD) Guidelines. Vienna, Austria: ECCO; 2010.
7. Weiner SJ, Schwartz A, Weaver F., et al Contextual errors and failures in individualizing patient care: a multicenter study. Ann Intern Med. 2010; 153: 69-75.
8. UK IBD Audit Steering Group. Report of the results for the national clinical audit of adult inflammatory bowel disease inpatient care in the UK. London, United Kingdom: Royal College of Physicians; 2011.
9. Raspe H, Conrad S, Muche-Borowski C. Evidence-based and consented pathways for patients with inflammatory bowel diseases (IBD). Z Gastroenterol. 2009; 47: 541-562.
10. Saibil F, Lai E, Hayward A., et al Self-management for people with inflammatory bowel disease. Can J Gastroenterol. 2008; 22: 281-287. (Pubitemid 351676389)
11. Department of Health. The Expert Patient: A New Approach to Chronic Disease Management for the 21st Century. London, United Kingdom: Department of Health; 2001.
12. World Health Organization. General principles of good chronic care 2004. Available at: http://www.who.int/hiv/pub/imai/generalprinciples082004.pdf Accessed May 25, 2013.
13. Conrad S, Hueppe A, Raspe H. Preference of patients with inflammatory bowel disease regarding information and shared decision-making: results from a cross-sectional survey in Germany. Z Gastroenterol. 2012; 50: 364-372.
14. Barlow J, Wright C, Sheasby J., et al Self-management approaches for people with chronic conditions: a review. Patient Educ Couns. 2002; 48: 177-187. (Pubitemid 36158880)
15. Wagner EH, Austin BT, von Korff M. Organizing care for patients with chronic illness. Milbank Q. 1996; 74: 511-544.
16. Wagner EH, Austin BT, Davis C, et al Improving chronic illness care: translating evidence into action. Health Aff (Millwood). 2001; 20: 64-78. (Pubitemid 33707442)
17. Gensichen J, Muth C, Butzlaff M., et al The future is chronic: German primary care and the Chronic Care Model-the comprehensive principles in the proactive treatment of the chronically ill. Z Ärztl Fortbild Quali-tätssich. 2006; 100: 365-374. (Pubitemid 44186755)
18. Coleman K, Austin BT, Brach C, et al Evidence on the Chronic Care Model in the new millennium. Health Aff (Millwood). 2009; 28: 75-85.
19. Warsi A, Wang PS, LaValley M.P., et al Self-management education programs in chronic disease: a systematic review and methodological critique of the literature. Arch Intern Med. 2004; 164: 1641-1649. (Pubitemid 39037943)
20. Gibson PG, Powell H, Coughlan J., et al Limited (information only) patient education programs for adults with asthma. Cochrane Database Syst Rev. 2002:CD001005.
21. Adams SG, Smith PK, Allan P.F., et al Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Arch Intern Med. 2007; 167: 551-561. (Pubitemid 46513224)
22. Effing T, Monninkhof EM, van der Valk PD, et al. Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2007:CD002990.
23. Nolte S, Osborne RH A systematic review of outcomes of chronic disease self-management interventions. Qual Life Res. 2013; 22: 1805-1816.
24. Clark NM, Griffiths C, Keteyian S.R., et al Educational and behavioral interventions for asthma: who achieves which outcomes? A systematic review. J Asthma Allergy. 2010; 3: 187-197.
25. Nunez DE, Keller C, Ananian CD A review of the efficacy of the self-management model on health outcomes in community-residing older adults with arthritis. Worldviews Evid Based Nurs. 2009; 6: 130-148.
26. Coulter A, Ellins J. Effectiveness of strategies for informing, educating, and involving patients. BMJ. 2007; 335: 24-27. (Pubitemid 47066902)
27. Barlow C, Cooke D, Mulligan K., et al A critical review of self-management and educational interventions in inflammatory bowel disease. Gastroenterol Nurs. 2010; 33: 11-18.
28. Rakshit RC, Mayberry JF What is the role of patient education in the care of IBD? Inflamm Bowel Dis. 2008; 14: 66-67.
29. Timmer A, Preiss JC, Motschall E, et al Psychological interventions for treatment of inflammatory bowel disease. Cochrane Database Syst Rev. 2011:CD006913.
30. Hueppe A. Aktivierung chronisch Kranker durch individualisierte Behandlungsempfehlungen-Beobachtungen aus einem Pilotprojekt zur Versorgung von Patientinnen und Patienten mit chronisch entzündlichen Darmerkrankungen. Gesundheitswesen. 2012; 74:A48.
31. Ackermann A. Biometrische Analysen von Stichproben. BiAS. für Windows. 10 ed. Darmstadt, Germany: Epsilon; 2013.
32. EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990; 16: 199-208.
33. Stark RG, Reitmeir P, Leidl R., et al Validity, reliability, and responsiveness of the EQ-5D in inflammatory bowel disease in Germany. Inflamm Bowel Dis. 2010; 16: 42-51.
34. Deck R, Mittag O, Hueppe A., et al Index zur Messung von Einschränkungen der Teilhabe (IMET)-Erste Ergebnisse eines ICF-orientierten Assessmentinstruments. Praxis Klinische Verhaltensmedizin Rehabil 2007; 76: 113-120.
35. Deck R. IMET. Index zur Messung von Einschränkungen der Teilhabe. In: Begel J, Wirtz M, Zwingmann C, eds. Diagnostische Verfahren in der Rehabilitation. Göttingen, Germany: Hogrefe; 2008: 372-374.
36. Bokemeyer B, Hardt J, Huppe D., et al Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry. J Crohns Colitis. 2013; 7: 355-368.
37. Best WR, Becktel JM, Singleton J.W., et al Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976; 70: 439-444.
38. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sul-phasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ. 1989; 298: 82-86. (Pubitemid 19032930)
39. Janke KH, Raible A, Bauer M., et al Questions on life satisfaction (FLZM) in inflammatory bowel disease. Int J Colorectal Dis. 2004; 19: 343-353. (Pubitemid 38868300)
40. Solberg IC, Lygren I, Cvancarova M., et al Predictive value of serologic markers in a population-based Norwegian cohort with inflammatory bowel disease. Inflamm Bowel Dis. 2009; 15: 406-414.
41. Henriksen M, Jahnsen J, Lygren I., et al Clinical course in Crohn's disease: results of a five-year population-based follow-up study (the IBSEN study). Scand J Gastroenterol. 2007; 42: 602-610. (Pubitemid 46633816)
42. Osborne RH, Elsworth GR, Whitfield K. The Health Education Impact Questionnaire (heiQ): an outcomes and evaluation measure for patient education and self-management interventions for people with chronic conditions. Patient Educ Couns. 2007; 66: 192-201. (Pubitemid 46575176)
43. Nolte S, Elsworth GR, Sinclair A.J., et al The extent and breadth of benefits from participating in chronic disease self-management courses: a national patient-reported outcomes survey. Patient Educ Couns. 2007; 65: 351-360. (Pubitemid 46241775)
44. Schuler M, Musekamp G, Faller H., et al Assessment of proximal outcomes of self-management programs: translation and psychometric evaluation of a German version of the Health Education Impact Questionnaire (heiQ). Qual Life Res. 2013; 22: 1391-1403.
45. Cloutier MM, Wakefield DB, Tsimikas J, et al Organizational attributes of practices successful at a disease management program. J Pediatr. 2009; 154: 290-295.
46. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979; 6: 65-70.
47. Abt K. Descriptive data analysis: a concept between confirmatory and exploratory data analysis. Methods Inf Med. 1987; 26: 77-88. (Pubitemid 17094791)
48. Field A. Discovering Statistics Using. IBM SPSS Statistics. 4th ed. London, United Kingdom: SAGE; 2013.
49. Hayes AF. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-based Approach. 1st ed. New York, NY: Guilford Pubn; 2013.
50. German Federal Office for Building and Regional Planning. Regional Planning Report. Bonn, Germany: German Federal Office for Building and Regional Planning; 2005.
51. Mittag O, Raspe H. A brief scale for measuring subjective prognosis of gainful employment: findings of a study of 4279 statutory pension insur-ees concerning reliability (Guttman scaling) and validity of the scale. Die Rehabil. 2003; 42: 169-174. (Pubitemid 36827517)
52. Bullinger M, Kirchberger I. Der SF-36 Fragebogen zum Gesundheitszustand (SF-36). Handbuch für die deutschsprachige Fragebogenversion. Göttingen, Germany: Hogrefe; 1998.
53. Rattay P, Butschalowsky H, Rommel A., et al Utilization of outpatient and inpatient health services in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013; 56: 832-844.
54. Jaeschke R, Singer J, Guyatt GH Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989; 10: 407-415. (Pubitemid 20025670)
55. Norman GR, Sloan JA, Wyrwich KW Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003; 41: 582-592.
56. Sonnenberg A. Age distribution of IBD hospitalization. Inflamm Bowel Dis. 2010; 16: 452-457.
57. Boonen A, Dagnelie PC, Feleus A, et al The impact of inflammatory bowel disease on labor force participation: results of a population sampled case-control study. Inflamm Bowel Dis. 2002; 8: 382-389. (Pubitemid 36411024)
58. Bernklev T, Jahnsen J, Henriksen M., et al Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006; 12: 402-412.
59. Wilson BS, Loennfors S, Hommes D.W., et al A European Crohn's and ulcerative colitis patient life IMPACT survey 2012. Available at: https://www.ecco-ibd.eu/publications/congress-abstract-s/abstracts-2012/item/ p406-a-euro.html?category-id=175. Accessed February 4, 2014.
60. Wilson BS, Loennfors S, Vermeire S., et al The true IMPACT of IBD. A European Crohn's and ulcerative colitis patient life IMPACT survey 2013. Available at: http://efcca-solutions.net/media/jointhefight/ImpactReport.pdf. Accessed February 4, 2014.
61. Sulz MC, Siebert U, Arvandi M., et al Predictors for hospitalization and outpatient visits in patients with inflammatory bowel disease: results from the Swiss Inflammatory Bowel Disease Cohort Study. Eur J Gastroenter-ol Hepatol. 2013; 25: 790-797.
62. Schoen C, Osborn R, How S.K., et al In chronic condition: experiences of patients with complex health care needs, in eight countries, 2008. Health Aff (Millwood). 2009; 28:w1-w16.
63. Scherer M, Hardt J, Blozik E., et al Pharmacotherapy in patients with ulcerative colitis. Z Gastroenterol. 2011; 49: 820-826.
64. Blumenstein I, Bock H, Weber C., et al Health care and cost of medication for inflammatory bowel disease in the Rhein-Main region, Germany: a multicenter, prospective, internet-based study. Inflamm Bowel Dis. 2008; 14: 53-60. (Pubitemid 351196869)
65. Ghosh S, Mitchell R. Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohns Colitis. 2007; 1: 10-20. (Pubitemid 350265728)
66. Haapamaki J, Turunen U, Roine R.P., et al Impact of demographic factors, medication and symptoms on disease-specific quality of life in inflammatory bowel disease. Qual Life Res. 2009; 18: 961-969.
67. Melmed GY, Siegel CA Quality improvement in inflammatory bowel disease. Gastroenterol Hepatol (NY). 2013; 9: 286-292.
68. Preiss JC, Blumenstein I, Zeuzem S., et al Versorgungsrealität und Versorgungspfade bei chronisch entzündlichen Darmerkrankungen (Morbus Crohn und Colitis ulcerosa). Z Gastroenterol. 2009; 47: 529-530.
69. Wood L, Egger M, Gluud L.L., et al Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ. 2008; 336: 601-605. (Pubitemid 351439518)
70. Hoffmann F, Icks A. Structural differences between health insurance funds and their impact on health services research: results from the Bertelsmann Health-Care Monitor. Gesundheitswesen. 2012; 74: 291-297.
71. Peyrin-Biroulet L. What is the patient's perspective: how important are patient-reported outcomes, quality of life and disability? Dig Dis. 2010; 28: 463-471.
72. Abraham BP, Sellin JH Disability in inflammatory bowel disease. Gas-troenterol Clin North Am. 2012; 41: 429-441.
73. Colombel JF. Measuring disability in IBD: the IBD disability index. Gastroenterol Hepatol (NY). 2013; 9: 300-302.
74. Peyrin-Biroulet L., Cieza A, Sandborn W.J., et al Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut. 2012; 61: 241-247.